Implementing ‘aggregation’ – the term used to describe pharmaceutical product unit-to-case hierarchy – is not mandatory in Europe, however industry delegates say there is incentive to push its adoption.
Drug counterfeiting – a 21st century solution to an age-old problem
Drug counterfeiting – a century solution to an age-old problem
Definitions of poor quality medicines. *As of January 2017, the WHO member state mechanism has recommended that the use of “substandard/spurious/falsely-labelled/falsified/counterfeit medical products” should be replaced with “substandard and falsified medical products”
The 2017 National Drug Threat Assessment (NDTA) has both good and bad news about the nation’s worsening overdose crisis. But like other federal agencies, the DEA has a disturbing tendency to massage statistics to make the role of opioid pain medication more significant than it actually is.